292 related articles for article (PubMed ID: 26578115)
1. Production of recombinant PvDBPII, receptor binding domain of Plasmodium vivax Duffy binding protein, and evaluation of immunogenicity to identify an adjuvant formulation for vaccine development.
Bhardwaj R; Shakri AR; Hans D; Gupta P; Fernandez-Becerra C; Del Portillo HA; Pandey G; Chitnis CE
Protein Expr Purif; 2017 Aug; 136():52-57. PubMed ID: 26578115
[TBL] [Abstract][Full Text] [Related]
2. Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax.
Gupta S; Singh S; Popovici J; Roesch C; Shakri AR; Guillotte-Blisnick M; Huon C; Menard D; Chitnis CE
Sci Rep; 2018 Jul; 8(1):10511. PubMed ID: 30002416
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans.
Martinez FJ; Guillotte-Blisnick M; Huon C; England P; Popovici J; Laude H; Arowas L; Ungeheuer MN; Reimer JM; Carter D; Reed S; Mukherjee P; Chauhan VS; Chitnis CE
Sci Rep; 2023 Aug; 13(1):13904. PubMed ID: 37626150
[TBL] [Abstract][Full Text] [Related]
5. Glycan masking of Plasmodium vivax Duffy Binding Protein for probing protein binding function and vaccine development.
Sampath S; Carrico C; Janes J; Gurumoorthy S; Gibson C; Melcher M; Chitnis CE; Wang R; Schief WR; Smith JD
PLoS Pathog; 2013; 9(6):e1003420. PubMed ID: 23853575
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.
Grimberg BT; Udomsangpetch R; Xainli J; McHenry A; Panichakul T; Sattabongkot J; Cui L; Bockarie M; Chitnis C; Adams J; Zimmerman PA; King CL
PLoS Med; 2007 Dec; 4(12):e337. PubMed ID: 18092885
[TBL] [Abstract][Full Text] [Related]
7. [Cloning, expression and identification of Plasmodium vivax Duffy binding protein region II of central China isolate].
Liu D; Xia H; Tao ZY; Chen Y; Fang Q; Wang XM; Sun X; Gao Y; Mai YQ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Aug; 24(4):474-7. PubMed ID: 23236803
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein.
Yazdani SS; Shakri AR; Mukherjee P; Baniwal SK; Chitnis CE
Vaccine; 2004 Sep; 22(27-28):3727-37. PubMed ID: 15315853
[TBL] [Abstract][Full Text] [Related]
9. Diversity pattern of Duffy binding protein sequence among Duffy-negatives and Duffy-positives in Sudan.
Hoque MR; Elfaki MMA; Ahmed MA; Lee SK; Muh F; Ali Albsheer MM; Hamid MMA; Han ET
Malar J; 2018 Aug; 17(1):297. PubMed ID: 30119671
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys.
Arévalo-Herrera M; Castellanos A; Yazdani SS; Shakri AR; Chitnis CE; Dominik R; Herrera S
Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):25-31. PubMed ID: 16291763
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.
Ntumngia FB; Schloegel J; McHenry AM; Barnes SJ; George MT; Kennedy S; Adams JH
Vaccine; 2013 Sep; 31(40):4382-8. PubMed ID: 23916294
[TBL] [Abstract][Full Text] [Related]
12. Natural acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein (PvDBP-II) equally block erythrocyte binding of homologous and heterologous expressed PvDBP-II on the surface of COS-7 cells.
Valizadeh V; Zakeri S; Mehrizi AA; Mirkazemi S; Djadid ND
Med Microbiol Immunol; 2016 Feb; 205(1):85-95. PubMed ID: 26243337
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium simium, a Plasmodium vivax-related malaria parasite: genetic variability of Duffy binding protein II and the Duffy antigen/receptor for chemokines.
Camargos Costa D; Pereira de Assis GM; de Souza Silva FA; Araújo FC; de Souza Junior JC; Braga Hirano ZM; Satiko Kano F; Nóbrega de Sousa T; Carvalho LH; Ferreira Alves de Brito C
PLoS One; 2015; 10(6):e0131339. PubMed ID: 26107662
[TBL] [Abstract][Full Text] [Related]
14. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.
King CL; Michon P; Shakri AR; Marcotty A; Stanisic D; Zimmerman PA; Cole-Tobian JL; Mueller I; Chitnis CE
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8363-8. PubMed ID: 18523022
[TBL] [Abstract][Full Text] [Related]
15. A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.
Hostetler JB; Sharma S; Bartholdson SJ; Wright GJ; Fairhurst RM; Rayner JC
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004264. PubMed ID: 26701602
[TBL] [Abstract][Full Text] [Related]
16. Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.
Cole-Tobian JL; Michon P; Biasor M; Richards JS; Beeson JG; Mueller I; King CL
Infect Immun; 2009 Sep; 77(9):4009-17. PubMed ID: 19564376
[TBL] [Abstract][Full Text] [Related]
17. Genetic diversity and natural selection of Duffy binding protein of Plasmodium vivax Korean isolates.
Ju HL; Kang JM; Moon SU; Bahk YY; Cho PY; Sohn WM; Park YK; Park JW; Kim TS; Na BK
Acta Trop; 2013 Jan; 125(1):67-74. PubMed ID: 23031445
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II.
Ntumngia FB; Barnes SJ; McHenry AM; George MT; Schloegel J; Adams JH
Clin Vaccine Immunol; 2014 Sep; 21(9):1215-23. PubMed ID: 24964808
[TBL] [Abstract][Full Text] [Related]
19. Fine specificity of Plasmodium vivax Duffy binding protein binding engagement of the Duffy antigen on human erythrocytes.
Siddiqui AA; Xainli J; Schloegel J; Carias L; Ntumngia F; Shoham M; Casey JL; Foley M; Adams JH; King CL
Infect Immun; 2012 Aug; 80(8):2920-8. PubMed ID: 22615246
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria.
He WQ; Shakri AR; Bhardwaj R; França CT; Stanisic DI; Healer J; Kiniboro B; Robinson LJ; Guillotte-Blisnick M; Huon C; Siba P; Cowman A; King CL; Tham WH; Chitnis CE; Mueller I
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0006987. PubMed ID: 30768655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
